DLXY Schedule 13D: CEO Xie controls 56.1% with 6-month lock-up
On 07/10/2025, Delixy Holdings Ltd (DLXY) Executive Chairman & CEO Xie Dongjian filed a Schedule 13D disclosing majority ownership.
Rhea-AI Filing Summary
On 07/10/2025, Delixy Holdings Ltd (DLXY) Executive Chairman & CEO Xie Dongjian filed a Schedule 13D disclosing majority ownership. Through wholly-owned BVI vehicle Mega Origin Holdings Ltd, he holds 9,176,000 ordinary shares, equal to 56.12 % of Delixy’s 16.35 million shares outstanding. All voting and dispositive power is sole; no shared power exists.
The stake arises from the issuer’s 2024 reorganization and 1:200 forward split. Mr. Xie states the shares were acquired to maintain control and that he will continue to direct strategy; no additional plans under Items 4(a-j) are currently disclosed.
A lock-up agreement dated 07/08/2025 bars any sale, pledge or transfer of the shares for six months after the final prospectus (07/09/2025), limiting near-term supply. No transactions occurred in the past 60 days, and neither Mr. Xie nor Mega Origin has criminal or civil proceedings. Citizenship: China; filing persons: Mr. Xie and Mega Origin.
Positive
- None.
Negative
- None.
Insights
TL;DR Majority insider stake and lock-up reinforce founder control; neutral governance impact.
The filing formalises Mr. Xie’s 56.1 % position, already implied in prospectus documents. Concentrated control aligns incentives but reduces minority influence and public float. The six-month lock-up curbs selling pressure during the initial post-IPO period, supporting price stability. No change to board structure or strategic intent is announced, so the disclosure is chiefly procedural.
TL;DR 13D confirms tight float; liquidity risk persists despite short lock-up.
With just 43.9 % of shares outside Mr. Xie’s control, DLXY will trade on a limited float, potentially heightening volatility. The six-month lock-up postpones but does not eliminate future supply. No funding source issues or planned share sales are noted, so near-term dilution risk is low. Overall, disclosure is routine with limited valuation impact.
FAQ
How much of Delixy (DLXY) does CEO Xie Dongjian own?
Why was this Schedule 13D filed?
Are there any ongoing legal proceedings involving the reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.